RenovoRx, Inc.
RNXT
$2.00
-$0.21-9.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 909.00K | 563.00K | 238.00K | 266.00K | 422.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 909.00K | 563.00K | 238.00K | 266.00K | 422.00K |
| Cost of Revenue | 143.00K | 84.00K | 28.00K | 53.00K | 152.00K |
| Gross Profit | 766.00K | 479.00K | 210.00K | 213.00K | 270.00K |
| SG&A Expenses | 2.92M | 2.72M | 2.23M | 1.73M | 1.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.26M | 4.03M | 3.26M | 3.37M | 3.10M |
| Operating Income | -3.35M | -3.47M | -3.02M | -3.10M | -2.68M |
| Income Before Tax | -2.91M | -3.52M | -2.94M | -2.91M | -2.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.91M | -3.52M | -2.94M | -2.91M | -2.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.91M | -3.52M | -2.94M | -2.91M | -2.90M |
| EBIT | -3.35M | -3.47M | -3.02M | -3.10M | -2.68M |
| EBITDA | -3.34M | -3.47M | -3.02M | -3.10M | -2.68M |
| EPS Basic | -0.06 | -0.09 | -0.08 | -0.08 | -0.08 |
| Normalized Basic EPS | -0.04 | -0.06 | -0.04 | -0.05 | -0.05 |
| EPS Diluted | -0.06 | -0.09 | -0.08 | -0.08 | -0.08 |
| Normalized Diluted EPS | -0.04 | -0.06 | -0.04 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 47.30M | 38.03M | 36.66M | 36.65M | 36.58M |
| Average Diluted Shares Outstanding | 47.30M | 38.03M | 36.66M | 36.65M | 36.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |